Cargando…
Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing
BACKGROUND: The ability to modify the genome of any cell at a precise location has drastically improved with the recent discovery and implementation of CRISPR/Cas9 editing technology. However, the capacity to introduce specific directed changes at given loci is hampered by the fact that the major ce...
Autores principales: | Robert, Francis, Barbeau, Mathilde, Éthier, Sylvain, Dostie, Josée, Pelletier, Jerry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550049/ https://www.ncbi.nlm.nih.gov/pubmed/26307031 http://dx.doi.org/10.1186/s13073-015-0215-6 |
Ejemplares similares
-
Protospacer Adjacent Motif (PAM)-Distal Sequences Engage CRISPR Cas9 DNA Target Cleavage
por: Cencic, Regina, et al.
Publicado: (2014) -
PAM multiplicity marks genomic target sites as inhibitory to CRISPR-Cas9 editing
por: Malina, Abba, et al.
Publicado: (2015) -
Inducible Genome Editing with Conditional CRISPR/Cas9 Mice
por: Katigbak, Alexandra, et al.
Publicado: (2018) -
Repurposing CRISPR/Cas9 for in situ functional assays
por: Malina, Abba, et al.
Publicado: (2013) -
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)